Bode Cellmark Forensics, Inc.

Bode Cellmark Forensics, Inc., doing business as Bode Technology, operates as a prime contractor providing forensic DNA analysis, expert witness testimony, genealogy investigations, and proficiency testing services to federal law enforcement and criminal justice agencies. The firm competes on full-and-open basis across all recent awards, with no SBA set-asides, and is a for-profit subsidiary of Laboratory Corporation of America Holdings (Labcorp).

Bode Technology's federal footprint is heavily concentrated in Department of Justice work, particularly expert witness services. The U.S. Attorney's Offices account for 489 awards (72% of the total) with combined potential value of $4.6 million—a high-volume, modest-dollar pattern reflecting repeated task orders for individual case support. By contrast, the FBI's Headquarters Division drives the dollar concentration with 33 awards worth $246.5 million combined potential value, anchored by a single $2.062 million labor-hours definitive contract (awarded September 2022) for laboratory division forensic support services. Immigration and Customs Enforcement contributes 13 awards valued at $29.5 million, and the Defense Health Agency holds 16 awards for proficiency testing and quality assurance at $964 thousand. Together, these four customer organizations account for 75% of combined potential value across 34 distinct agencies served.

Bode Technology's core capability set reflects its laboratory and investigative focus: expert witness services (460 PSC-coded awards), reference laboratory testing (53 awards), and litigative consulting (36 awards) dominate the recent contract mix. The company delivers DNA testing and case reviews under a $28.98 million GSA Multiple Award Schedule (52 task orders, $36 million combined potential value) covering laboratory equipment, R&D services, and professional law enforcement support—labor portfolio spans casework assistants through forensic examiners at hourly rates from $67.72 to $144.34, with security clearances required across most roles. Additional vehicles include a Defense Health Agency indefinite delivery contract ($387.338 thousand, through November 2026) for proficiency testing, a U.S. Customs and Border Protection single-award BPA ($70 thousand, through August 2026) for DNA testing support, and an FBI indefinite delivery contract (DJFJFBI12288, 14 task orders, $23.1 million combined potential value). Recent representative work includes a $1.95 million FireFox IDC delivery order for laboratory support (FBI, 2024), a $243.582 thousand Army Central Command purchase order for DNA analysis in Iraq-Syria operations (January 2023), and genealogy support services for the Marine Corps locating relatives of 50 Marines unaccounted for from past wars ($71.28 thousand, September 2023).

Activity has grown substantially—12 awards in 2022 through 40 in 2025—but pace softened in 2026 (24 awards through July). Forty-five awards (combined potential value $1.2 million) reach ultimate completion inside the next twenty-four months, creating recompete exposure primarily among small-dollar U.S. Attorney's Offices task orders. Bode Technology operates as a prime on 99% of awards; sub-award exposure is minimal (eight sub-awards, primarily forensic testing support delivered to Research Triangle Institute on the NamUs program). SCI-reportable invoicing totaled $3 million across FY2022–FY2023 (10.4 FTEs in FY2022, 9.3 FTEs in FY2023, zero in FY2024), with government-paid median hourly rates around $68.85/hr on reportable contracts—a sharp contrast to the FBI and ICE dollar dominance, indicating that high-value vehicles run leaner staffing models or are classified beyond SCI reporting thresholds.

The company has received three federal research grants from the National Institute of Justice: a $659.287 thousand award (effective January 2024) for evaluating target enrichment and SNP genotyping of skeletal remains to advance forensic investigative genetic genealogy; a second NIJ award evaluating microhaplotype sequencing for DNA mixture deconvolution (effective January 2023); and a $437.383 thousand grant (January 2022–June 2023) for comparative evaluation of genotyping technologies in sexual assault casework. This R&D footprint positions Bode Technology as both a service provider and innovation partner in forensic DNA methodology development for federal law enforcement.

Bode performs forensic DNA analysis, instrument validation services and DNA research & development. Bode makes DNA evidence collection products.